Navigation Links
VetCentric Releases Findings of Pet Owner Survey
Date:5/7/2009

Data Results in New Compounded Medication Program

GLEN BURNIE, Md., May 7 /PRNewswire/ -- VetCentric, Inc., the nation's largest practice-to-home delivery veterinary pharmacy today announced the results of its recent online survey of more than 1,200 pet owners from across the U.S.

Key findings indicate that pet owners feel very strongly about having convenient services and options that help them improve compliance. It also indicated a very strong preference for ordering medications directly through their veterinary clinics to maintain veterinarian involvement. Specifically:

  • 96% of pet owners stated that it was important to be able to order their pet's medication through their veterinarian to ensure that the vet remained involved with the pet's care (51% stated that this is "very important")
  • 90% of pet owners stated it was important to have the convenience of home delivery for their pet's medications
  • 87% of pet owners stated it was important to have automatic refills of the pet's medications so they didn't have to worry about missing a dose
  • 87% of pet owners stated it was important to have a variety of medication forms and flavorings that make it easier for pets to take their medications

To meet the needs pet owners identified in this research and support its partner practices, VetCentric recently launched a new compounded medications program that provides free home delivery while encouraging treatment regime compliance. The program includes free 2nd day shipping for first fills and free standard shipping for all refills when the prescription is set up to automatically refill. Complete information about the program is available through the recently launched compounding microsite at www.vetcentric.com/compounding.

"The results of this survey strongly support VetCentric's core belief that veterinarian involvement is crucial to maintaining healthy pets. It's very exciting to see that pet owners feel strongly about both the convenience of home delivery and keeping their veterinarian involved in their pet's care. This data was instrumental in the development of our new compounded medications program," said Ted Root, President and CEO of VetCentric.

More than 1,200 pet owners completed the survey and all of them are clients of clinics that presently have a VetCentric account. Approximately 50% of respondents have placed at least one order through VetCentric.

About VetCentric:

VetCentric, Inc., a privately-held company headquartered in the Baltimore-Washington area, is the only national veterinary-focused pharmacy offering home delivery of FDA and EPA approved pharmaceuticals, compounded medications and diets to pet owners on behalf of veterinary clinics. Its comprehensive suite of services provides clinics with an online store that allows customized product selection and pricing, home delivery and client communications. VetCentric firmly supports the Veterinarian-Client-Patient relationship in all its business practices, allowing veterinarians to stay at the center of their patients' care while improving service, encouraging compliance and decreasing costs.

In the past 10 years, VetCentric has partnered with more than 9,000 veterinary clinics to fill in excess of 2 million orders for nearly 500,000 pet owners. Its pharmacy complies with the licensing and inspection requirements of all states in which it does business. For more information, please visit www.vetcentric.com.


'/>"/>
SOURCE VetCentric, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. VetCentric Partners with Dechra Veterinary Products
2. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
3. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
4. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
5. Verdict One Releases Directory of Board Certified Attorneys for Consumers
6. Academy releases emergency preparedness tools to enable millions more people to shelter in place
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. MITEM Releases Blue Iris eLaborate 8.6
9. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages of traumatic brain ... conduct a survey that takes a closer look at cases of TBI being managed ... causes of TBI among the aging population, and identifies the challenges associated with their ...
(Date:2/10/2016)... MI (PRWEB) , ... February 10, 2016 , ... ... Apifiny® across their network of laboratory service centers across the country. Launched ... to aid clinicians in the detection of prostate cancer. Apifiny order volume exceeded 3,000 ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... announced that it has been awarded the prestigious Distinguished Emerald Club of the ... program conducted by BoardRoom magazine, one of the most respected trade publications serving ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics, who is celebrating ... evolved from humble beginnings to being an internationally recognized leader in their industry. , ... today”, said Charlie Lawrence, President of Workrite. “Workrite recognized the importance of good ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... Face and Body Specialists are delighted to welcome a new addition to their ... Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... and SAN DIEGO , ... Inc., a global leader in viral gene therapy manufacturing, ... treatments for congestive heart failure and other chronic diseases, ... a scalable manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) ... --> --> ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... Feb. 10, 2016  Oxis International Inc. (OTC/QB: OXIS) ... was described as a "clinical trial triumph" after one ... into complete cancer remission. Daniel Vallera ... Masonic Cancer Center. --> Daniel Vallera ... Masonic Cancer Center. --> An article ...
Breaking Medicine Technology: